Patent details
EP2032126 Title: RABEPRAZOLE FORMULATION
Basic Information
- Publication number:
- EP2032126
- PCT Application Number:
- PCT/EP/2007/005691
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP077648897
- PCT Publication Number:
- WO/2008/000463
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- RABEPRAZOLE FORMULATION
- French Title of Invention:
- PRÉPARATION PHARMACEUTIQUE CONTENANT DU RABÉPRAZOLE
- German Title of Invention:
- RABEPRAZOL-FORMULIERUNG
- SPC Number:
Dates
- Filing date:
- 27/06/2007
- Grant date:
- 27/07/2011
- EP Publication Date:
- 27/07/2011
- PCT Publication Date:
- 03/01/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 11/03/2009
- EP B1 Publication Date:
- 27/07/2011
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 27/06/2012
- Expiration date:
- 27/06/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 27/06/2007
- Name:
- LEK Pharmaceuticals d.d.
- Address:
- Verovskova 57, 1526 Ljubljana, Slovenia (SI)
Inventor
1
- Name:
- JURECIC Rok
- Address:
- Slovenia (SI)
2
- Name:
- JAKLIC Miha Tomaz
- Address:
- Slovenia (SI)
Priority
- Priority Number:
- 06013440
- Priority Date:
- 29/06/2006
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- Main IPC Class:
- A61K 9/36;
| Filing date | Document type | Number of pages |
|---|